Men who have trained for decades as elite endurance athletes, like cyclists or marathoners, tend to have more fatty deposits in their heart arteries than healthy men who exercise moderately—even when both groups are fit and have normal cholesterol and blood pressure.
Scientific Claim
Lifelong endurance athletes aged 45–70 with no traditional cardiovascular risk factors have a higher prevalence of coronary plaques, including non-calcified and mixed plaques in proximal coronary segments, compared to similarly healthy non-athletes, suggesting that extreme long-term endurance exercise may increase coronary atherosclerotic burden despite favorable metabolic profiles.
Original Statement
“Lifelong endurance sports was associated with having ≥1 coronary plaque [odds ratio (OR) 1.86, 95% confidence interval (CI) 1.17–2.94], ≥ 1 proximal plaque (OR 1.96, 95% CI 1.24–3.11), ≥ 1 non-calcified plaque (OR 1.95, 95% CI 1.12–3.40), ≥ 1 non-calcified proximal plaque (OR 2.80, 95% CI 1.39–5.65), and ≥1 mixed plaque (OR 1.78, 95% CI 1.06–2.99) as compared to a healthy non-athletic lifestyle.”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
association
Can only show association/correlation
Assessment Explanation
The study is an observational cohort with no randomization; the use of 'associated with' and reporting of adjusted odds ratios correctly reflects the correlational nature of the findings without implying causation.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Systematic Review & Meta-AnalysisLevel 1aWhether lifelong endurance exercise consistently increases coronary plaque burden across diverse populations and whether this translates to higher cardiovascular event rates.
Whether lifelong endurance exercise consistently increases coronary plaque burden across diverse populations and whether this translates to higher cardiovascular event rates.
What This Would Prove
Whether lifelong endurance exercise consistently increases coronary plaque burden across diverse populations and whether this translates to higher cardiovascular event rates.
Ideal Study Design
A meta-analysis of 15+ prospective cohort studies (n>10,000 total) comparing lifelong endurance athletes (≥30 years of training, ≥10 h/week) to age-matched healthy non-athletes, all with CTCA-measured plaque burden and 10+ years of follow-up for MACE, adjusting for BMI, lipids, BP, and smoking history.
Limitation: Cannot prove causation or isolate the effect of exercise from genetic or dietary confounders.
Randomized Controlled TrialLevel 1bWhether increasing endurance training volume over time directly causes increased plaque formation in previously sedentary individuals.
Whether increasing endurance training volume over time directly causes increased plaque formation in previously sedentary individuals.
What This Would Prove
Whether increasing endurance training volume over time directly causes increased plaque formation in previously sedentary individuals.
Ideal Study Design
A 15-year double-blind RCT of 500 healthy men aged 40–50 randomized to either 15 h/week endurance training (cycling/running) or 3 h/week moderate activity, with annual CTCA to track plaque progression, lipid panels, and cardiac events as primary outcomes.
Limitation: Ethically and practically unfeasible due to long duration and difficulty blinding exercise intervention.
Prospective Cohort StudyLevel 2bWhether higher plaque burden in lifelong athletes predicts future heart attacks or death over time.
Whether higher plaque burden in lifelong athletes predicts future heart attacks or death over time.
What This Would Prove
Whether higher plaque burden in lifelong athletes predicts future heart attacks or death over time.
Ideal Study Design
A 20-year prospective cohort of 2,000 male endurance athletes and 2,000 matched controls, all undergoing baseline and 5-year CTCA, with continuous monitoring of cardiovascular events, adjusting for diet, sleep, and genetic risk scores.
Limitation: Still observational; cannot rule out residual confounding from unmeasured lifestyle factors.
Case-Control StudyLevel 3bWhether athletes who suffer cardiac events have higher plaque burden or different plaque composition than athletes who do not.
Whether athletes who suffer cardiac events have higher plaque burden or different plaque composition than athletes who do not.
What This Would Prove
Whether athletes who suffer cardiac events have higher plaque burden or different plaque composition than athletes who do not.
Ideal Study Design
A case-control study comparing 200 endurance athletes with acute coronary syndrome to 400 matched athletes without events, using high-resolution CTCA and intravascular imaging to assess plaque vulnerability features.
Limitation: Retrospective design limits ability to determine temporal sequence of plaque development and event.
Animal Model StudyLevel 4In EvidenceWhether extreme endurance exercise directly triggers vascular inflammation, endothelial damage, or plaque instability via biological pathways.
Whether extreme endurance exercise directly triggers vascular inflammation, endothelial damage, or plaque instability via biological pathways.
What This Would Prove
Whether extreme endurance exercise directly triggers vascular inflammation, endothelial damage, or plaque instability via biological pathways.
Ideal Study Design
A 2-year study in 80 male ApoE−/− mice randomized to voluntary wheel running (moderate) vs. forced treadmill running (extreme, 6 h/day, 5 days/week), with serial histology, cytokine profiling, and plaque composition analysis at 6-month intervals.
Limitation: Mouse physiology and plaque biology differ significantly from humans; cannot directly translate to clinical risk.
Evidence from Studies
Supporting (1)
Lifelong endurance exercise and its relation with coronary atherosclerosis